Arkolith/Insider Trading/DFTX/Form 4

Barrow Robert

Chief Executive Officer, DirectorDefinium Therapeutics, Inc. (DFTX) · full profile →Form 4 · filed Jun 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.3M
Net Open-Market Flow
-$1.3M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 25, 2026Sell(S)29K$45.03$1.3M1.1M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-285562) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML